Phase II study of biweekly S-1 and oxaliplatin combination chemotherapy in metastatic colorectal cancer and pharmacogenetic analysis

被引：0
作者：
Junshik Hong
Sae-Won Han
Hye Seon Ham
Tae-Yong Kim
In Sil Choi
Byung-Su Kim
Do-Youn Oh
Seock-Ah Im
Gyeong Hoon Kang
Yung-Jue Bang
Tae-You Kim
机构：
[1] Seoul National University Hospital,Department of Internal Medicine
[2] Seoul National University College of Medicine,Cancer Research Institute
[3] Seoul Municipal Boramae Hospital,Department of Internal Medicine
[4] Seoul National University College of Medicine,Department of Pathology
[5] Graduate School of Convergence Science and Technology,Department of Molecular Medicine & Biopharmaceutical Sciences
[6] Seoul National University,undefined
来源：
Cancer Chemotherapy and Pharmacology | 2011年 / 67卷
关键词：
Colorectal cancer; Oxaliplatin; S-1; Chemotherapy;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1323 / 1331
页数：8
相关论文
共 289 条
  • [1] Won YJ(2009)Nationwide cancer incidence in Korea, 2003–2005 Cancer Res Treat 41 122-131
  • [2] Sung J(1998)Efficacy of intravenous continuous infusion of fluorouracil compared with bolus administration in advanced colorectal cancer J Clin Oncol 16 301-308
  • [3] Jung KW(2008)Efficacy of oxaliplatin plus capecitabine or infusional fluorouracil/leucovorin in patients with metastatic colorectal cancer: a pooled analysis of randomized trials J Clin Oncol 26 5910-5917
  • [4] Kong HJ(2000)Leucovorin and fluorouracil with or without oxaliplatin as first-line treatment in advanced colorectal cancer J Clin Oncol 18 2938-2947
  • [5] Park S(2008)Randomized phase III study of capecitabine plus oxaliplatin compared with fluorouracil/folinic acid plus oxaliplatin as first-line therapy for metastatic colorectal cancer J Clin Oncol 26 2006-2012
  • [6] Shin HR(1996)Development of a novel form of an oral 5-fluorouracil derivative (S-1) directed to the potentiation of the tumor selective cytotoxicity of 5-fluorouracil by two biochemical modulators Anticancer Drugs 7 548-557
  • [7] Park EC(2000)Phase II study of S-1, a novel oral fluorophyrimidine derivative, in patients with metastatic colorectal carcinoma. S-1 Cooperative Colorectal Carcinoma Study Group Br J Cancer 83 141-145
  • [8] Ahn YO(2004)Phase II study of oral S-1 for treatment of metastatic colorectal carcinoma Cancer 100 2355-2361
  • [9] Hwang IK(2003)EORTC Early Clinical Studies Group early phase II trial of S-1 in patients with advanced or metastatic colorectal cancer Br J Cancer 88 648-653
  • [10] Lee DH(2006)The role of pharmacogenetics in cancer therapeutics Br J Clin Pharmacol 62 35-46
12345678910